STOCK TITAN

ABVC BioPharma (ABVC) Stock News, Dec 2023-Mar 2024

ABVC NASDAQ

ABVC BioPharma, Inc. develops clinical-stage therapeutic products in ophthalmology, central nervous system disorders, and oncology/hematology. Its pipeline includes botanically derived drug candidates and the ophthalmology medical device Vitargus, with disclosed programs tied to Major Depressive Disorder, Attention Deficit Hyperactivity Disorder, Non-Small Cell Lung Cancer, and retinal surgery applications.

Recurring company news covers global licensing agreements, milestone and licensing-fee receipts, partner activity involving BioLite, BioFirst, Rgene, AiBtl BioPharma, ForSeeCon Eye Corporation, and OncoX BioPharma, and updates on clinical development, regulatory preparation, and reported financial results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.59%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
60.83%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.41%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags

FAQ

What is the current stock price of ABVC BioPharma (ABVC)?

ABVC BioPharma (ABVC) last closed at $0.9400.

What is the market cap of ABVC BioPharma (ABVC)?

The market cap of ABVC BioPharma (ABVC) is approximately $25.4M.